Sale!

TBC1D24 Gene Early Infantile Epileptic Encephalopathy Type 16 NGS Genetic DNA Test

Original price was: R9,350.Current price is: R6,700.

-28%

As parents, watching your infant experience unexplained seizures can be terrifying and overwhelming. Our TBC1D24 Gene Early Infantile Epileptic Encephalopathy Type 16 NGS Genetic DNA Test provides the answers you desperately need. For only ZAR 6,700 (regularly ZAR 9,350), this advanced genetic test uses next-generation sequencing technology to identify mutations in the TBC1D24 gene that cause severe epilepsy in infants. We understand the anxiety and uncertainty you’re facing, which is why our test delivers accurate, reliable results within 3-4 weeks. With nationwide coverage across South Africa including Johannesburg, Cape Town, and Durban, you can access world-class genetic testing close to home. Our comprehensive approach includes genetic counselling to help you understand your family’s risk and make informed decisions about your child’s health. Take the first step toward clarity and peace of mind today.

📞 24/7 South African Support Team Call : +27 6412 56421

  • ✓ ISO Accredited Lab Reports
  • ✓ Free Genetic Counseling Included
  • 🔒 100% Confidential & Secure Testing
Guaranteed Safe Checkout

TBC1D24 Gene Epilepsy Test | ZAR 6
TBC1D24 Gene Early Infantile Epileptic Encephalopathy Type 16 NGS Genetic DNA Test
R9,350 Original price was: R9,350.R6,700Current price is: R6,700.

[wpforms id=”1190″ title=”true” description=”Request a call back”]

Finding Answers for Your Infant’s Unexplained Seizures

When your baby experiences seizures that don’t respond to standard treatments, the fear and uncertainty can feel overwhelming. You’re not alone in this journey, and there are answers available. Our TBC1D24 Gene Early Infantile Epileptic Encephalopathy Type 16 test provides the clarity you need to understand your child’s condition and make informed treatment decisions.

Understanding the TBC1D24 Gene Test

This specialised genetic test examines the TBC1D24 gene, which plays a crucial role in brain development and function. When mutations occur in this gene, they can cause Early Infantile Epileptic Encephalopathy Type 16 – a severe form of epilepsy that typically begins in the first months of life. Our test uses advanced Next-Generation Sequencing (NGS) technology to provide comprehensive analysis with exceptional accuracy.

The test requires only a simple blood sample or a single drop of blood on an FTA card, making it accessible even for the youngest patients. What sets our approach apart is the inclusion of genetic counselling, where we create a detailed family history to better understand your child’s genetic background.

Is This Test Right for Your Child?

This test is specifically designed for infants and young children who exhibit:

  • Unexplained seizures beginning in early infancy
  • Seizures that don’t respond to standard anti-epileptic medications
  • Developmental delays or regression following seizure onset
  • Abnormal brain activity patterns on EEG
  • Family history of early-onset epilepsy or neurological conditions

If your child has been experiencing any of these symptoms, this test could provide the answers you’ve been searching for.

Why Early Detection Matters for Your Child’s Future

Getting a precise diagnosis through genetic testing can transform your child’s treatment journey. With accurate identification of the TBC1D24 mutation, healthcare providers can:

  • Develop targeted treatment strategies specific to your child’s genetic condition
  • Avoid ineffective medications and unnecessary side effects
  • Provide accurate prognosis and developmental expectations
  • Offer appropriate early intervention services
  • Guide family planning decisions for future pregnancies

Early diagnosis means earlier intervention, which can significantly improve long-term outcomes for children with genetic epilepsy conditions.

Understanding Your Results – Clear Guidance Every Step

We understand that waiting for genetic test results can be an anxious time. That’s why we provide comprehensive support throughout the process:

  • Clear, understandable reports written in plain language
  • Detailed consultation with our genetic specialists to explain your results
  • Personalised recommendations for next steps and treatment options
  • Ongoing support and resources for managing your child’s condition

Your results will clearly indicate whether a TBC1D24 gene mutation was detected and what this means for your child’s care and development.

Transparent Pricing – Exceptional Value for Peace of Mind

Service Regular Price Special Price Savings
TBC1D24 Gene Test with Genetic Counselling ZAR 9,350 ZAR 6,700 ZAR 2,650

Turnaround Time: 3-4 weeks
Sample Required: Blood or extracted DNA or one drop of blood on FTA card

This comprehensive package includes the genetic test, analysis, and essential genetic counselling session – everything you need for a complete understanding of your child’s condition.

Why South African Families Trust Oracle Genomics

  • Nationwide Coverage: Accessible testing centres in Johannesburg, Cape Town, Durban, Pretoria and across South Africa
  • Medical Expertise: Tests supervised by qualified neurologists and genetic specialists
  • Advanced Technology: State-of-the-art NGS technology for maximum accuracy
  • Proven Reliability: Trusted by healthcare providers throughout South Africa
  • Patient-Centred Care: Empathetic support from understanding professionals

Take the First Step Toward Answers Today

Don’t let uncertainty about your child’s seizures continue to cause anxiety. Early detection through genetic testing can provide the clarity needed to make the best decisions for your child’s health and future.

Book your genetic counselling session and testing today:

  • Call our dedicated helpline: [Phone Number]
  • Visit our website to schedule online
  • Contact your nearest testing centre in Johannesburg, Cape Town, or Durban

Every day matters when it comes to your child’s neurological development. Take action now to get the answers your family deserves.